Logo Logo
Switch Language to German
Emons, Guenter; Steiner, Eric; Vordermark, Dirk; Uleer, Christoph; Bock, Nina; Paradiess, Kerstin; Ortmann, Olaf; Aretz, Stefan; Mallmann, Peter; Kurzeder, Christian; Hagen, Volker; Oorschot, Birgitt van; Hoecht, Stefan; Feyer, Petra; Egerer, Gerlinde; Friedrich, Michael; Cremer, Wolfgang; Prott, Franz-Josef; Horn, Lars-Christian; Proempeler, Heinrich; Langrehr, Jan; Leinung, Steffen; Beckmann, Matthias W.; Kimmig, Rainer; Letsch, Anne; Reinhardt, Michael; Alt-Epping, Bernd; Kiesel, Ludwig; Menke, Jan; Gebhardt, Marion; Steinke-Lange, Verena; Rahner, Nils; Lichtenegger, Werner; Zeimet, Alain; Hanf, Volker; Weis, Joachim; Müller, Michael; Henscher, Ulla; Schmutzler, Rita K.; Meindl, Alfons; Hilpert, Felix; Panke, Joan Elisabeth; Strnad, Vratislav; Niehues, Christiane; Dauelsberg, Timm; Niehoff, Peter; Mayr, Doris; Grab, Dieter; Kreissl, Michael; Witteler, Ralf; Schorsch, Annemarie; Mustea, Alexander; Petru, Edgar; Hübner, Jutta; Rose, Anne Derke; Wight, Edward; Tholen, Reina; Bauerschmitz, Gerd J.; Fleisch, Markus; Juhasz-Boess, Ingolf; Sigurd, Lax; Runnebaum, Ingo; Tempfer, Clemens; Nothacker, Monika J.; Bloedt, Susanne; Follmann, Markus; Langer, Thomas; Raatz, Heike; Wesselmann, Simone; Erdogan, Saskia (2018): Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer. In: Geburtshilfe und Frauenheilkunde, Vol. 78, No. 10: pp. 949-970
Full text not available from 'Open Access LMU'.


The first German interdisciplinary S3-guideline on the diagnosis, therapy and follow-up of patients with endometrial cancer was published in April 2018. Funded by German Cancer Aid as part of an Oncology Guidelines Program, the lead coordinators of the guideline were the German Society of Gynecology and Obstetrics (DGGG) and the Gynecological Oncology Working Group (AGO) of the German Cancer Society (DKG). Purpose The use of evidence-based, risk-adapted therapy to treat low-risk women with endometrial cancer avoids unnecessarily radical surgery and non-useful adjuvant radiotherapy and/or chemotherapy. This can significantly reduce therapy-induced morbidity and improve the patient's quality of life as well as avoiding unnecessary costs. For women with endometrial cancer and a high risk of recurrence, the guideline defines the optimal surgical radicality together with the appropriate chemotherapy and/or adjuvant radiotherapy where required. The evidence-based optimal use of different therapeutic modalities should improve survival rates and the quality of life of these patients. The S3-guideline on endometrial cancer is intended as a basis for certified gynecological cancer centers. The aim is that the quality indicators established in this guideline will be incorporated in the certification processes of these centers. Methods The guideline was compiled in accordance with the requirements for S3-level guidelines. This includes, in the first instance, the adaptation of source guidelines selected using the DELBI instrument for appraising guidelines. Other consulted sources include reviews of evidence which were compiled from literature selected during systematic searches of literature databases using the PICO scheme. In addition, an external biostatistics institute was commissioned to carry out a systematic search and assessment of the literature for one area of the guideline. The identified materials were used by the interdisciplinary working groups to develop suggestions for Recommendations and Statements, which were then modified during structured consensus conferences and/or additionally amended online using the DELPHI method with consent being reached online. The guideline report is freely available online. Recommendations Part 1 of this short version of the guideline presents recommendations on epidemiology, screening, diagnosis and hereditary factors, The epidemiology of endometrial cancer and the risk factors for developing endomentrial cancer are presented. The options for screening and the methods used to diagnose endometrial cancer including the pathology of the cancer are outlined. Recommendations are given for the prevention, diagnosis, and therapy of hereditary forms of endometrial cancer.

Search for authors